19 April 2017
Adam Dangoor, Adam.Dangoor

Over 250 members attended the 13th annual conference, this year hosted in Bristol. The conference goes from strength to strength and we thank all those who submitted posters, or attended this valuable meeting. There were a wide variety of sessions by invited speakers covering subjects including the management of neurofibromatosis, the latest data concerning neoadjuvant chemotherapy […]

Continue Reading

27 March 2017
Luan Suckling, luan.suckling

Oral Presentation Winner:  Leo Feinberg Surgical Management within a Tertiary Referral Service Leads to Improved Disease Specific Survival of Patients with Radiation-associated Angiosarcoma of the Breast 1st Poster Prize:  Mariona Chicón Bosch Cancer stem-like cells isolated from Ewing’s sarcoma samples provide unique insight into tumour heterogeneity   2nd Poster Prize (two 2nd prize poster winners): […]

Continue Reading

The Beatson West of Scotland Cancer Centre (BWOSCC) is seeking expressions of interest in initially, a long term locum Consultant Clinical Oncologist to join the Sarcoma team and TYA oncology, (another tumour site specific interest to be discussed with the Clinical Director). The Beatson West of Scotland Cancer Centre (BWoSCC) is one of the United Kingdom’s […]

Continue Reading

19 September 2016
adrian, adrian

The BSG is proud to launch its new website. We are hoping the new site will give our members a better location to find the resources and everything they need to do with Sarcoma. Thanks to Luan, Anita and Adrian, here it is!

Continue Reading

Pazopanib (Votrient) The BSG has been informed that pazopanib (Votrient from GSK) for advanced soft tissue sarcoma will not be referred to NICE by the Department of Health. This is understood to be because the numbers of patients are too small to justify the use of the NICE Single Technology Appraisal process, and that the […]

Continue Reading

15 August 2016
adrian, adrian

Best Young Researcher 2016: George Watkinson     Two presentations:                   Post-operative nomogram for retroperitoneal sarcoma is able to accurately predict three and five year survival of patients in the retrospective Northern RPS database George Watkinson Synergistic Activity with combination of MDM2-p53 inhibition and ionising radiation in retroperitoneal […]

Continue Reading

Previous Page